13.04.2014 Views

CP13/6 - CRD IV for Investment Firms - Financial Conduct Authority

CP13/6 - CRD IV for Investment Firms - Financial Conduct Authority

CP13/6 - CRD IV for Investment Firms - Financial Conduct Authority

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>CP13</strong>/6<br />

<strong>CRD</strong> <strong>IV</strong> <strong>for</strong> <strong>Investment</strong> <strong>Firms</strong><br />

CRR<br />

article<br />

FCA<br />

Handbook<br />

reference –<br />

if existing<br />

discretion<br />

Area of national discretion<br />

Does the<br />

FCA intend<br />

to exercise<br />

the relevant<br />

discretion from<br />

1 January 2014?<br />

354(6) Transitional discretion until end 2017 where the FCA<br />

may allow 0% own funds requirements in relation to<br />

pairs of currencies that are demonstrably perfectly<br />

positively correlated.<br />

Yes<br />

363(1) BIPRU<br />

7.10.1R<br />

to BIPRU<br />

7.10.17G<br />

366(4) BIPRU<br />

7.10.106G<br />

The FCA shall grant a VaR permission to a firm that<br />

complies with the requirements in sections 2, 3 and 4<br />

of this article.<br />

Article 366(4) states that the FCA can use its discretion<br />

to limit the VaR multiplier add-on resulting from<br />

backtesting exceptions under hypothetical changes,<br />

where the number of backtesting exceptions under<br />

actual changes does not result from deficiencies in a<br />

firm’s internal model.<br />

Yes<br />

Yes<br />

367(1)<br />

(b)<br />

BIPRU<br />

7.10.39 R<br />

to BIPRU<br />

7.10.45G,<br />

BIPRU<br />

7.10.53 R<br />

to BIPRU<br />

7.10.55G,<br />

BIPRU<br />

7.10.68 G<br />

This Article requires a firm to justify to the FCA the<br />

exclusion from its risk management model of a risk<br />

factor incorporated into its pricing model.<br />

Yes<br />

373 BIPRU<br />

7.10.55B R<br />

FCA to grant permission be<strong>for</strong>e firms are allowed to<br />

include listed equity positions in their Incremental Risk<br />

Charge (IRC) model.<br />

Yes<br />

377(1)-<br />

(4)<br />

BIPRU<br />

7.10.55T R<br />

to BIPRU<br />

7.10.55YR<br />

FCA shall grant a firm with a VaR permission an<br />

additional authorisation to use an internal model to<br />

calculate market risk of positions in the correlation<br />

trading portfolio.<br />

Yes<br />

380 BIPRU<br />

14.4.7G<br />

FCA may waive the capital requirements relating to<br />

settlement risk if a system wide failure of a settlement<br />

or clearing occurs until the situation is rectified.<br />

Yes<br />

382 An institution can include securities financing<br />

transactions in the calculation of own funds required<br />

if the FCA determines that the institution’s CVA risk<br />

exposures arising from those transactions are material.<br />

Yes<br />

395(1) BIPRU<br />

10.5.6R,<br />

BIPRR<br />

10.5.7G,<br />

BIPRU<br />

10.6.32R<br />

396(1) BIPRU<br />

10.6.33G<br />

FCA may set a lower limit than €150 million or 25% of<br />

an institutions eligible capital.<br />

FCA may waive on a case by case basis compliance<br />

with the Large Exposures limits. A waiver would be<br />

permitted in under certain circumstances and <strong>for</strong> a<br />

‘limited period of time’ <strong>for</strong> the firm to bring itself into<br />

compliance with the Large Exposure limit.<br />

No<br />

Yes<br />

86 July 2013<br />

<strong>Financial</strong> <strong>Conduct</strong> <strong>Authority</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!